Serum Separation Gel Global Market Report 2024

The serum separation gel market size has grown strongly in recent years. It will grow from $8.22 billion in 2023 to $8.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The expansion observed during the historical period can be attributed to several factors, including the surge in current healthcare expenditure, increased demand for diagnostic testing, growth of the healthcare industry, expansion of research and development activities, and the rise in the prevalence of chronic diseases.

The serum separation gel market size is expected to see strong growth in the next few years. It will grow to $12.58 billion in 2028 at a compound annual growth rate (CAGR) of 9%. The anticipated growth in the forecast period can be attributed to several key factors, including the increasing incidence of hematologic disorders, a heightened emphasis on point-of-care testing, a rise in the number of contract research organizations, expansion in emerging markets, and the growing demand for personalized medicine. Major trends expected during this period encompass the application of personalized medicine, the development of novel gel formulations, an increased focus on eco-friendly and sustainable practices, integration with digital health technologies, and a surge in research for infectious disease diagnostics.

The serum separation gel market is poised for growth driven by the rising demand for diagnostic testing. Diagnostic testing involves identifying diseases or conditions in individuals by analyzing biological samples like blood or tissue for specific markers or abnormalities. The increasing demand for diagnostic testing stems from its role in detecting diseases early, aiding in effective treatment, and guiding preventive healthcare measures. Serum separation gel plays a crucial role in diagnostic testing by separating serum from blood cells, enabling accurate analysis of biochemical markers and disease detection. For example, data from March 2024 by the House of Commons indicates a 13% increase in diagnostic tests in January 2024 compared to January 2020, underscoring the growth in demand for diagnostic testing and its impact on the serum separation gel market.

Key players in the serum separation gel market are focusing on developing innovative product solutions like serum fast separator tubes to stay competitive. Serum fast separator tubes are designed with specialized gel or clot activator additives that facilitate rapid serum separation following centrifugation. For instance, in May 2023, Greiner Bio-One introduced the VACUETTE CAT Serum Fast Separator tube, which enables complete coagulation of whole blood samples in about 5 minutes, offering a significant time advantage over standard serum tubes. The tube's interior is coated with blood clot activator and thrombin, and it contains a gel barrier between serum and solid components. Thrombin accelerates the clotting process in blood samples, enhancing efficiency in diagnostic testing processes.

In October 2021, Abcam made a strategic acquisition of BioVision Inc. for $340 million to bolster its immunoassay capabilities and expand its range of kits and assays in Eugene. This acquisition aligns with Abcam's goal of meeting the growing demand in the life sciences industry and enhancing its position as a leader in innovative research tools. BioVision Inc., a US-based biotechnology company, specializes in providing various research tools, including serum separation gel, contributing to Abcam's growth and success in the market.

Major companies operating in the serum separation gel market are Cardinal Health Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Corning Incorporated, Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, Greiner Bio-One International GmbH, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, InterVac Technology Corporation, BioVision Inc., Deltalab S.L., Narang Medical Limited, Biosigma S.p.A., BIOSIGMA S.r.l., Helena Biosciences, FL Medical Srl, Kabe Labortechnik GmbH.

North America was the largest region in the serum separation gel market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the serum separation gel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum separation gel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Serum separation gel is a specialized substance utilized to isolate serum from whole blood samples, streamlining subsequent analysis in clinical and research environments. It is incorporated into blood collection tubes to establish a physical barrier between serum and blood cells, aiding in the separation process during centrifugation.

The primary types of serum separation gel include integrated tubes and standalone gel formulations. Integrated tubes feature blood collection tubes pre-coated or equipped with serum separation gels, simplifying serum isolation during sample collection. These formulations may include powder gel or liquid gel variations and are utilized across various sectors, including hospitals, clinics, pharmaceutical and biotechnology firms, diagnostic laboratories, and blood banks.

The serum separation gel market research report is one of a series of new reports that provides serum separation gel market statistics, including serum separation gel industry global market size, regional shares, competitors with serum separation gel market share, detailed serum separation gel market segments, market trends, and opportunities, and any further data you may need to thrive in the serum separation gel industry. This serum separation gel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The serum separation gel market consists of sales of silica-based and polymer-based serum separation gels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.